| The NO–cGMP–K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin MI Ortiz, V Granados-Soto, G Castañeda-Hernández Pharmacology Biochemistry and Behavior 76 (1), 187-195, 2003 | 169 | 2003 |
| The role of biosimilars in the treatment of rheumatic diseases T Dörner, V Strand, G Castañeda-Hernández, G Ferraccioli, JD Isaacs, ... Annals of the rheumatic diseases 72 (3), 322-328, 2013 | 145 | 2013 |
| Pharmacological evidence for the activation of K+ channels by diclofenac MI Ortiz, JE Torres-López, G Castañeda-Hernández, R Rosas, ... European journal of pharmacology 438 (1-2), 85-91, 2002 | 132 | 2002 |
| Assessing the immunogenicity of biopharmaceuticals C Pineda, G Castañeda Hernández, IA Jacobs, DF Alvarez, C Carini BioDrugs 30, 195-206, 2016 | 131 | 2016 |
| Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test JE Torres-López, MI Ortiz, G Castañeda-Hernández, R Alonso-López, ... Life Sciences 70 (14), 1669-1676, 2002 | 128 | 2002 |
| A new model to assess analgesic activity: Pain‐induced functional impairment in the rat (PIFIR) FJ López‐Muñoz, LA Salazar, G Castañeda‐Hernández, JE Villarreal Drug Development Research 28 (2), 169-175, 1993 | 121 | 1993 |
| Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac V Granados-Soto, FJ Flores-Murrieta, G Castañeda-Hernández, ... European journal of pharmacology 277 (2-3), 281-284, 1995 | 106 | 1995 |
| The role of biosimilars in the treatment of rheumatic diseases T Dorner, V Strand, G Castaneda-Hernandez, G Ferraccioli, JD Isaacs, ... Annals of the Rheumatic Diseases, 2013 | 98 | 2013 |
| Pharmacokinetic-pharmacodynamic modeling: why? J Pérez-Urizar, V Granados-Soto, FJ Flores-Murrieta, ... Archives of medical research 31 (6), 539-545, 2000 | 84 | 2000 |
| Synergistic effect of the interaction between naproxen and citral on inflammation in rats MI Ortiz, MP González-García, HA Ponce-Monter, ... Phytomedicine 18 (1), 74-79, 2010 | 76 | 2010 |
| Efficacy and safety of 4‐aminopyridine in patients with long‐term spinal cord injury: A randomized, double‐blind, placebo‐controlled trial I Grijalva, G Guízar‐Sahagún, G Castaneda‐Hernández, D Mino, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (7 …, 2003 | 75 | 2003 |
| Isolation, identification and molecular docking as cyclooxygenase (COX) inhibitors of the main constituents of Matricaria chamomilla L. extract and its synergistic interaction … MI Ortiz, E Fernández-Martínez, LE Soria-Jasso, I Lucas-Gómez, ... Biomedicine & Pharmacotherapy 78, 248-256, 2016 | 73 | 2016 |
| Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis G Lugo, G Castaneda-Hernandez Critical care medicine 25 (5), 806-811, 1997 | 70 | 1997 |
| Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies G Castañeda-Hernández, Z Szekanecz, E Mysler, VF Azevedo, ... Joint Bone Spine 81 (6), 471-477, 2014 | 68 | 2014 |
| The epidemiologic burden of hepatitis C virus infection in Latin America SM Szabo, M Bibby, Y Yuan, BMK Donato, R Jiménez-Mendez, ... Annals of hepatology 11 (5), 623-635, 2015 | 67 | 2015 |
| Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat JE Torres-López, FJ López-Muñoz, G Castañeda-Hernández, ... Journal of Pharmacology and Experimental Therapeutics 282 (2), 685-690, 1997 | 66 | 1997 |
| Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico R Jimenez-Mendez, F Uribe-Salas, P López-Guillen, L Cisneros-Garza, ... Annals of hepatology 9 (1), 33-39, 2010 | 65 | 2010 |
| Synergistic effects between codeine and diclofenac after local, spinal and systemic administration JM Jiménez-Andrade, MI Ortiz, J Pérez-Urizar, P Aguirre-Bañuelos, ... Pharmacology Biochemistry and Behavior 76 (3-4), 463-471, 2003 | 61 | 2003 |
| Pharmacokinetics of oral nifedipine in different populations G Castañeda‐Hernández, C Hoyo‐Vadillo, JA Palma‐Aguirre, ... The Journal of Clinical Pharmacology 33 (2), 140-145, 1993 | 59 | 1993 |
| The combination of naproxen and citral reduces nociception and gastric damage in rats MI Ortiz, ML Ramírez-Montiel, MP González-García, HA Ponce-Monter, ... Archives of pharmacal research 33, 1691-1697, 2010 | 58 | 2010 |
